AQR Capital Management LLC Purchases 506,440 Shares of GRAIL, Inc. $GRAL

AQR Capital Management LLC raised its holdings in GRAIL, Inc. (NASDAQ:GRAL - Free Report) by 61.0% during the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,337,163 shares of the company's stock after purchasing an additional 506,440 shares during the quarter. AQR Capital Management LLC owned 3.79% of GRAIL worth $33,991,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Wells Fargo & Company MN bought a new stake in shares of GRAIL during the 4th quarter valued at approximately $90,000. GAMMA Investing LLC grew its stake in shares of GRAIL by 4,102.5% during the first quarter. GAMMA Investing LLC now owns 25,131 shares of the company's stock worth $642,000 after buying an additional 24,533 shares during the last quarter. Wealth Enhancement Advisory Services LLC bought a new stake in shares of GRAIL during the first quarter worth $719,000. Deutsche Bank AG acquired a new position in shares of GRAIL during the fourth quarter worth $1,001,000. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC bought a new position in shares of GRAIL in the 4th quarter valued at $1,201,000.

Insider Activity at GRAIL

In other news, President Joshua J. Ofman sold 9,692 shares of the company's stock in a transaction dated Monday, June 30th. The shares were sold at an average price of $52.00, for a total transaction of $503,984.00. Following the transaction, the president owned 492,076 shares in the company, valued at approximately $25,587,952. This represents a 1.93% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, major shareholder Chun R. Ding sold 339,800 shares of the stock in a transaction that occurred on Tuesday, July 1st. The stock was sold at an average price of $49.53, for a total value of $16,830,294.00. Following the completion of the transaction, the insider owned 3,305,055 shares in the company, valued at approximately $163,699,374.15. The trade was a 9.32% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 361,694 shares of company stock worth $17,780,266 in the last quarter. Company insiders own 1.85% of the company's stock.

GRAIL Stock Performance

Shares of NASDAQ:GRAL traded down $1.66 during midday trading on Friday, hitting $36.99. 248,775 shares of the stock were exchanged, compared to its average volume of 1,299,216. The business's 50-day moving average price is $35.84 and its 200 day moving average price is $35.55. GRAIL, Inc. has a 12 month low of $12.33 and a 12 month high of $63.99. The stock has a market capitalization of $1.33 billion, a price-to-earnings ratio of -2.82 and a beta of 3.18.

GRAIL (NASDAQ:GRAL - Get Free Report) last announced its earnings results on Tuesday, August 12th. The company reported ($3.18) EPS for the quarter, missing the consensus estimate of ($3.14) by ($0.04). GRAIL had a negative return on equity of 16.64% and a negative net margin of 329.86%.The company had revenue of $35.54 million for the quarter, compared to analyst estimates of $37.57 million. As a group, sell-side analysts expect that GRAIL, Inc. will post -15.15 EPS for the current year.

GRAIL Company Profile

GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.